Welcome to LookChem.com Sign In|Join Free
  • or
DOPA 3-phosphate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

97321-86-3

Post Buying Request

97321-86-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

97321-86-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 97321-86-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,3,2 and 1 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 97321-86:
(7*9)+(6*7)+(5*3)+(4*2)+(3*1)+(2*8)+(1*6)=153
153 % 10 = 3
So 97321-86-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H12NO7P/c10-6(9(12)13)3-5-1-2-7(11)8(4-5)17-18(14,15)16/h1-2,4,6,11H,3,10H2,(H,12,13)(H2,14,15,16)/t6-/m0/s1

97321-86-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-2-amino-3-(4-hydroxy-3-phosphonooxyphenyl)propanoic acid

1.2 Other means of identification

Product number -
Other names L-Tyrosine,3-(phosphonooxy)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:97321-86-3 SDS

97321-86-3Upstream product

97321-86-3Downstream Products

97321-86-3Relevant academic research and scientific papers

CARBIDOPA AND L-DOPA PRODRUGS AND THEIR USE TO TREAT PARKINSON'S DISEASE

-

Paragraph 0300; 0309, (2016/05/24)

The present disclosure relates to (a) carbidopa prodrugs, (b) pharmaceutical combinations and compositions comprising a carbidopa prodrug and/or an L-dopa prodrug, and (c) methods of treating Parkinson's disease and associated conditions comprising administering a carbidopa prodrug and an L-dopa prodrug to a subject with Parkinson's disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 97321-86-3